Express Scripts - Prescription for success

One of the true growth stocks that is having upward price momentum even during this slight market contraction is Express Scripts (ESRX).  Even now as revealed on Barchart, while over 70% of stocks are trading below their 20 day moving average this company continues to hold above its 20, 50 and 100 day moving average.  They control costs, manage their margins extremely well and have an A financial stability rating.  I'd buy this stock on momentum alone.

Express Scripts, Inc. (ESRX) is one of the largest pharmacy benefit management companies in North America. Through facilities in the states and Canada, the company serves thousands of client groups, including managed care organizations, insurance carriers, third-party administrators, employers and union-sponsored benefit plans.

Factors you should consider:

Technical Factors:

• 80% Barchart short term technical buy signal
• Trend Spotter buy signal
• Trades above its 20, 50 and 100 day moving averages
• 12 new highs and up 8.55% in the last month
• Relative Strength Index 68.68% and rising
• Trades around 60.15 with a 50 day moving average of 55.71

Fundamental Factors:

• Wall Street brokerage analysts still have positive recommendations released
• Analysts have released 9 strong buy, 13 buy, 8 hold and only 1 negative report for their clients
• Sales are projected to increase by 1.90% this year and 3.40% next year
• Earnings are estimated to increase by 27.60% this year, 23.80% next year and 18.16% annually for the next 5 years
• Double digit earnings growth should always get your attention

General Investor Sentiment:

• On Motley Fool 888 readers have expressed an opinion
• CAPS members vote 644 to 41 for the stock to beat the market
• The more experienced All Stars agree 191 to 12

Summary:  While other stocks falter you should look for stocks that have financial strength and continues to fight the tide.  Add Express Scripts (ESRX) to your watch lists.